1. Home
  2. GWH vs SKYE Comparison

GWH vs SKYE Comparison

Compare GWH & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ESS Tech Inc.

GWH

ESS Tech Inc.

HOLD

Current Price

$1.02

Market Cap

22.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.78

Market Cap

29.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GWH
SKYE
Founded
2011
2012
Country
United States
United States
Employees
62
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
29.1M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
GWH
SKYE
Price
$1.02
$0.78
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$2.25
$15.00
AVG Volume (30 Days)
680.4K
142.5K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$33.99
N/A
Revenue Next Year
$1,328.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.57
52 Week High
$13.87
$5.75

Technical Indicators

Market Signals
Indicator
GWH
SKYE
Relative Strength Index (RSI) 49.83 46.64
Support Level $0.74 $0.71
Resistance Level $1.22 $0.83
Average True Range (ATR) 0.10 0.07
MACD 0.02 -0.00
Stochastic Oscillator 74.61 32.00

Price Performance

Historical Comparison
GWH
SKYE

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. It develops and manufactures long-duration energy storage systems based on iron flow battery technology. The company's batteries use earth-abundant materials, including iron, salt, and water, and are designed for high cycle life and recyclability. It operates as a single business operating segment, which includes all activities related to the design, engineering, and manufacturing of the company's long duration energy storage products. The company's revenue is derived from the sale of its energy storage products and from service contracts.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: